Emerging immunotherapies for glioblastoma.

MLA

Desai, Rupen, et al. “Emerging Immunotherapies for Glioblastoma.” Expert Opinion on Emerging Drugs, vol. 21, no. 2, June 2016, pp. 133–45. EBSCOhost, https://doi.org/10.1080/14728214.2016.1186643.

APA

Desai, R., Suryadevara, C. M., Batich, K. A., Farber, S. H., Sanchez-Perez, L., & Sampson, J. H. (2016). Emerging immunotherapies for glioblastoma. Expert Opinion on Emerging Drugs, 21(2), 133–145. https://doi.org/10.1080/14728214.2016.1186643

Chicago

Desai, Rupen, Carter M Suryadevara, Kristen A Batich, S Harrison Farber, Luis Sanchez-Perez, and John H Sampson. 2016. “Emerging Immunotherapies for Glioblastoma.” Expert Opinion on Emerging Drugs 21 (2): 133–45. doi:10.1080/14728214.2016.1186643.